1.
High Uptake of Respiratory Syncitial Virus Prevention for Neonates in a Military Treatment Facility.
J Pediatr
; 273: 114144, 2024 Jun 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38876155
RESUMO
We investigated the uptake of nirsevimab for infants and the bivalent respiratory syncytial virus prefusion F (RSVPreF) vaccine for pregnant persons as measures for RSV prevention during an infant's birth hospitalization in a military treatment facility. We found >85% uptake between October 2023 to February 2024. These data may aid health systems plan for future RSV seasons.
2.
Pediatr Rev
; 43(12): e36-e40, 2022 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36450639
3.
Neoreviews
; 21(12): e828-e830, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33262209
4.
J Perinatol
; 39(1): 8-10, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30305714